Azitra (NYSEAMERICAN:AZTR – Get Free Report) will likely be releasing its results before the market opens on Monday, February 23rd. Analysts expect Azitra to post earnings of ($0.37) per share for the quarter.
Azitra Price Performance
Shares of AZTR opened at $0.17 on Friday. Azitra has a 1 year low of $0.16 and a 1 year high of $2.66. The stock has a 50 day simple moving average of $0.26 and a 200-day simple moving average of $0.53.
Azitra Company Profile
Azitra Inc is a clinical-stage biopharmaceutical company focused on developing live bacterial therapies for dermatological conditions. Headquartered in Cambridge, Massachusetts, the company leverages its proprietary ActoBiotic platform to formulate topical treatments that aim to modulate the skin’s native microbial ecosystem.
The company’s lead investigational therapies are being evaluated in early-phase clinical studies for inflammatory skin disorders, including atopic dermatitis and other conditions characterized by microbial imbalance.
Read More
- Five stocks we like better than Azitra
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- How a Family Trust May Be Able To Help Preserve Your Wealth
- This makes me furious
Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.
